VEGF 165 (AA 207-371) protein (His tag)
-
- Target
- VEGF 165
- Protein Type
- Recombinant
- Protein Characteristics
- AA 207-371
-
Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- His tag
- Application
- SDS-PAGE (SDS)
- Characteristics
- VEGF165, 207-371aa, Human, His tag, E.coli
- Purity
- > 90 % by SDS - PAGE
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5mg/ml (determined by Bradford assay)
- Buffer
- Liquid. In 20mM Tris-HCl(pH8.5), 50%glycerol, 5mM DTT, 200mM NaCl, 2mM EDTA
- Storage
- 4 °C
-
- Target
- VEGF 165
- Background
- Vascular endothelial growth factor (VEGF) is homodimeric, heparin-binding glycoprotein involved in both angiogenesis and vasculogenesis. VEGF is expressed as multiple alternately spliced isoforms of VEGF121, 165, 189 and 206. VEGF binds to the receptor tyrosine kinases VEGF R1 (Flt-1) and VEGF R2 (KDR/Flk-1) to activate signal transduction and regulate both physiological and pathological angiogenesis. Recombinant human VEGF165 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by conventional chromatography, after refolding of the isolated inclusion bodies in a renaturation buffer. Synonyms: Vascular endothelial growth factor A isoform d, VPF, VEGF, VEGF-A. NCBI no.: NP_001020539
- Molecular Weight
- 21.3kDa (185aa), conformed by MALDI-TOF
-